Cargando…

Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran

BACKGROUND: Factor V Leiden (FVL) and factor II c.∗97G>A (rs1799963) are genetic risk factors for venous thromboembolism. Their contribution to coronary artery disease (CAD) is less clear. OBJECTIVES: This study aimed to investigate the association between FVL, rs1799963, and premature CAD in Ira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agosti, Pasquale, Mancini, Ilaria, Sadeghian, Saeed, Pagliari, Maria Teresa, Abbasi, Seyed Hesameddin, Pourhosseini, Hamidreza, Boroumand, Mohammadali, Lotfi-Tokaldany, Masoumeh, Pappalardo, Emanuela, Maino, Alberto, Rosendaal, Frits R., Peyvandi, Flora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926016/ https://www.ncbi.nlm.nih.gov/pubmed/36798900 http://dx.doi.org/10.1016/j.rpth.2023.100048

Ejemplares similares

Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study
por: Maino, Alberto, et al.
Publicado: (2023)

Factors Associated with Depressive Symptoms in Young Adults with Coronary Artery Disease: Tehran Heart Center's Premature Coronary Atherosclerosis Cohort (THC-PAC) Study
por: Abbasi, Seyed Hesameddin, et al.
Publicado: (2016)

Introducing the Tehran Heart Center's Premature Coronary Atherosclerosis Cohort: THC-PAC Study
por: Abbasi, Seyed Hesameddin, et al.
Publicado: (2015)

Combined Aortic and Mitral Valve Stenosis in Mucopolysaccharidosis Syndrome Type I-S: A Report of a Rare Case
por: Sadeghian, Hakimeh, et al.
Publicado: (2021)

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012)

Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review
por: Maino, Alberto, et al.
Publicado: (2015)

Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
por: Elson, Sarah L., et al.
Publicado: (2020)

Prothrombin Gene G20210A Variant in Angiographically Documented Patients with Coronary Artery Stenosis
por: Pourgholi, Leyla, et al.
Publicado: (2019)

Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021)

Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
por: Teremmahi Ardestani, Majid, et al.
Publicado: (2013)

Acute Myocardial Infarction in Patients with Hereditary Thrombophilia—A Focus on Factor V Leiden and Prothrombin G20210A
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023)

Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study
por: Saadatnia, Mohammad, et al.
Publicado: (2015)

Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
por: Zhang, Peijin, et al.
Publicado: (2014)

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
por: Kardi, Mohammad Taghi, et al.
Publicado: (2018)

The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
por: Garrido-Barbero, Maria, et al.
Publicado: (2019)

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020)

Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
por: Pagliari, Maria Teresa, et al.
Publicado: (2021)

Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease
por: Samarah, Fekri, et al.
Publicado: (2018)

Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study
por: Ahmed, Nadir A., et al.
Publicado: (2019)

Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study
por: Maino, Alberto, et al.
Publicado: (2019)

Large‐scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population
por: Raptopoulou, Alkistis, et al.
Publicado: (2022)

MTHFR C677T, Prothrombin G20210A, and Factor V Leiden (G1691A) Polymorphism and Beta-Thalassemia Risk: A Meta-Analysis
por: Nigam, Nitu, et al.
Publicado: (2020)

Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
por: Riva, Silvia, et al.
Publicado: (2020)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
por: John-Olabode, Sarah O, et al.
Publicado: (2021)

Comparison of Echocardiographic Markers of Cardiac Dyssynchrony and Latest Left Ventricular Activation Site in Heart Failure Patients with and without Left Bundle Branch Block
por: Lotfi-Tokaldany, Masoumeh, et al.
Publicado: (2013)

Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population
por: D'Amico, Mario, et al.
Publicado: (2013)

Response to Cardiac Resynchronization Therapy in Cardiomyopathy Patients with Right Bundle Branch Block
por: Zand, Sara, et al.
Publicado: (2023)

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013)

Factor VLeiden and Prothrombin G20210A Gene Polymorphisms in Patients with Coronary Artery Disease
por: Ercan, Bahadır, et al.
Publicado: (2008)

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
por: Ferrari, Barbara, et al.
Publicado: (2014)

Effects of Enhanced External Counterpulsation on Heart Rate Recovery in Patients with Coronary Artery Disease
por: Sardari, Akram, et al.
Publicado: (2018)

C1019T Polymorphism in the Connexin 37 Gene and Myocardial Infarction Risk in Premature Coronary Artery Disease
por: Sheikhvatan, Mehrdad, et al.
Publicado: (2017)

Relationship between the Severity of Coronary Artery Disease and Cardiovascular Risk Factors in Acute Coronary Syndrome: Based on Tehran Heart Center’s Data Registry
por: Omidi, Negar, et al.
Publicado: (2020)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

Factor V Leiden interferes with protein S activity assay
por: Panaget, Baptiste, et al.
Publicado: (2023)

Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?
por: Abbasi, Seyed Hesameddin, et al.
Publicado: (2010)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1nrceeb1asbo04iopnqd04g3gk